In schizophrenia, chronic fatigue syndrome- and fibromyalgia-like symptoms are driven by breakdown of the paracellular pathway with increased zonulin and immune activation-associated neurotoxicity
Michael Maes, Laura Andrés-Rodríguez, Aristo Vojdani, Sunee Sirivichayakul, Decio S. Barbosa, Buranee Kanchanatawan
doi: https://doi.org/10.1101/2021.05.09.21256897
Michael Maes
aDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
bDepartment of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
cIMPACT Strategic Research Center, Deakin University, Geelong, Australia
M.D., Ph.D.Laura Andrés-Rodríguez
dGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain
Aristo Vojdani
eImmunosciences Lab., Inc, Los Angeles, CA, USA
fCyrex Labs, LLC, Phoenix, AZ, USA
gDepartment of Preventive Medicine, Loma Linda University, Loma Linda, CA, USA
Ph.D.Sunee Sirivichayakul
hFaculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Ph.D.Decio S. Barbosa
iHealth Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil
Ph.D.Buranee Kanchanatawan
aDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
M.D.Data Availability
The dataset generated during and/or analyzed during the current study will be available from the corresponding author upon reasonable request and once the dataset has been fully exploited by the authors.
Posted May 11, 2021.
In schizophrenia, chronic fatigue syndrome- and fibromyalgia-like symptoms are driven by breakdown of the paracellular pathway with increased zonulin and immune activation-associated neurotoxicity
Michael Maes, Laura Andrés-Rodríguez, Aristo Vojdani, Sunee Sirivichayakul, Decio S. Barbosa, Buranee Kanchanatawan
medRxiv 2021.05.09.21256897; doi: https://doi.org/10.1101/2021.05.09.21256897
In schizophrenia, chronic fatigue syndrome- and fibromyalgia-like symptoms are driven by breakdown of the paracellular pathway with increased zonulin and immune activation-associated neurotoxicity
Michael Maes, Laura Andrés-Rodríguez, Aristo Vojdani, Sunee Sirivichayakul, Decio S. Barbosa, Buranee Kanchanatawan
medRxiv 2021.05.09.21256897; doi: https://doi.org/10.1101/2021.05.09.21256897
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)